Tag archive for ‘small molecule drugs’
Can-Fite is part of Israel startup nation
Gil Tanenbaum On Wednesday, October 1st, 2014

Can-Fite BioPharma Liver Drug Gets US Patent

Israel’s Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, has received a patent in the US for its More...

Jewish Business News Service On Sunday, November 17th, 2013

Israeli Can-Fite BioPharma Announces Approval of ADR Listing on NYSE MKT

– The cancer and inflammatory drug development company will list its Level II ADRs on the NYSE MKT on Tuesday , November 19, 2013 under the ticker symbol “CANF”. – Israeli Can-Fite BioPharma More...

Wordpress site Developed by Fixing WordPress Problems